Literature DB >> 8800501

The molecular basis of haemophilia A and B.

F Giannelli1, P M Green.   

Abstract

Most families with haemophilia A or B carry gene defects of independent origin. Haemophilia B is mostly due to small changes in the factor IX gene affecting either its transcription, mRNA maturation, mRNA translation or the fine structure of factor IX. Only 2-3% of patients show gross deletions or rearrangements. The great variety of missense mutations reported to cause haemophilia B indicates that this multidomain protein is highly constrained. Less is known about the factor VIII gene as fully efficient mutation detection procedures only became available in 1991. This, however, led to the discovery that almost half the severe cases of haemophilia A or a fifth of all cases are due to frequently occurring inversions caused by homologous intra-chromosome (-chromatid) recombination between repeated sequences 9.5 kb long. Of the three repeats one is in intron 22 of the factor VIII gene and two are 400-500 kb more telomeric. They are 99.8% similar to each other. The spectrum of the other haemophilia A mutations is similar to that of haemophilia B. Since 1983 mounting evidence has shown that in both haemophilias the nature of the mutation is important in predisposing to the inhibitor complication.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8800501     DOI: 10.1016/s0950-3536(96)80059-x

Source DB:  PubMed          Journal:  Baillieres Clin Haematol        ISSN: 0950-3536


  15 in total

Review 1.  Tolerance induction by viral in vivo gene transfer.

Authors:  Eric Dobrzynski; Roland W Herzog
Journal:  Clin Med Res       Date:  2005-11

2.  Analysis of Bcl I and Xba I polymorphism in factor VIII gene to detect carriers of haemophilia a in Andhra Pradesh.

Authors:  P Aruna Prabhavathi; Tajamul Hussain; G N Mallikarjuna Rao; Mp Js Anandaraj
Journal:  Indian J Clin Biochem       Date:  2002-01

3.  Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B.

Authors:  P M Green; S Saad; C M Lewis; F Giannelli
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 4.  Update on clinical gene therapy for hemophilia.

Authors:  George Q Perrin; Roland W Herzog; David M Markusic
Journal:  Blood       Date:  2018-12-17       Impact factor: 22.113

Review 5.  Haemophilia A and haemophilia B: molecular insights.

Authors:  D J Bowen
Journal:  Mol Pathol       Date:  2002-04

Review 6.  The bleeding child; is it NAI?

Authors:  A E Thomas
Journal:  Arch Dis Child       Date:  2004-12       Impact factor: 3.791

Review 7.  Haemophilia A and haemophilia B: molecular insights.

Authors:  D J Bowen
Journal:  Mol Pathol       Date:  2002-02

8.  Induction of immune tolerance to coagulation factor IX antigen by in vivo hepatic gene transfer.

Authors:  Federico Mingozzi; Yi-Lin Liu; Eric Dobrzynski; Antje Kaufhold; Jian Hua Liu; YuQin Wang; Valder R Arruda; Katherine A High; Roland W Herzog
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

Review 9.  Hemophilia Care in the Pediatric Age.

Authors:  Marta Bertamino; Francesca Riccardi; Laura Banov; Johanna Svahn; Angelo Claudio Molinari
Journal:  J Clin Med       Date:  2017-05-19       Impact factor: 4.241

10.  Neonatal Hemophilia: A Rare Presentation.

Authors:  Nuno Ferreira; Elisa Proença; Cristina Godinho; Dulce Oliveira; Ana Guedes; Sara Morais; Carmen Carvalho
Journal:  Pediatr Rep       Date:  2015-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.